RIGL

RIGL Accumulated OCI

-$148.00KQuarterly · USD

Period ending:

RIGL FY Accumulated OCIUSD
RIGL FY Accumulated OCI1999-12-31: -$5.81M2000-12-31: -$5.79M2001-12-31: -$2.41M2002-12-31: -$773.00K2003-12-31: -$213.00K2004-12-31: -$276.00K2005-12-31: -$118.00K2006-12-31: $13.00K2007-12-31: $198.00K2008-12-31: $396.00K2009-12-31: -$12.00K2010-12-31: -$38.00K2011-12-31: $6.00K2012-12-31: $82.00K2013-12-31: $47.00K2014-12-31: -$7.00K2015-12-31: -$44.00K2016-12-31: -$18.00K2017-12-31: -$82.00K2018-12-31: -$24.00K2019-12-31: $23.00K2020-12-31: -$4.00K2021-12-31: -$102.00K2022-12-31: -$153.00K2023-12-31: $8.00K2024-12-31: $10.00K2025-12-31: $181.00K$396.00K-$5.81M
1999-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

RIGL accumulated oci history

Accumulated other comprehensive income (loss). The available annual fiscal periods series contains 27 observations from Dec 31, 1999 to Dec 31, 2025.

Rigel Pharmaceuticals Inc Accumulated OCI — Annual fiscal periods (USD)
Period endingAccumulated OCI (USD)
181,000
10,000
8,000
-153,000
-102,000
-4,000
23,000
-24,000
-82,000
-18,000
-44,000
-7,000
47,000
82,000
6,000
-38,000
-12,000
396,000
198,000
13,000
-118,000
-276,000
-213,000
-773,000
-2,408,000
-5,790,000
-5,814,000

Compare accumulated oci

All RIGL financial metrics · RIGL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.